Cosmos Health Raises its Pharma Cell partnership in Albania, expecting to surpass 54,000 units in Annual

OrdersOn 21 July 2026, Cosmos Health bolstered its presence in Balkan healthcare by expanding its alliance with Pharma Cell in Albania. This move is expected to increase annual orders to over 54,000 units and to improve pharmaceutical distribution, regional healthcare supply chain efficiency, and long-term growth prospects across Southeast Europe.

Cosmos Health Inc. expanded its partnership with Pharma Cell in Albania, further strengthening its presence in Southeast Europe's pharma sector. The alliance focuses on improving access to high-quality medicines and streamlining distribution, demonstrating increased confidence in Cosmos Health’s products and supply chain. Projected annual orders will exceed 54,000 units, reflecting growing demand and supporting regional strategy. Albania’s improving healthcare infrastructure and increasing pharmaceutical needs present development opportunities.

By accelerating order volume, it targets to stabilize inventory management, increase efficiency, and deepen relationships with healthcare providers. The expansion aligns with Cosmos Health’s goal to grow through regional partnerships. The increased orders will support revenue, production planning, and supply chain optimization. It also aids Cosmos Health's expansion into neighboring Southeast European infrastructure, promoting domestic networks, highlighting the dominance of regional alliances in the industry. Overall, these collaborations help strengthen supply security, regulatory compliance, and competitive edge, ensuring easy patient access and long-term cooperation.

Impact on the Healthcare Distribution Industry

The global healthcare distribution market size was valued at USD 1.19 trillion in 2025 and is predicted to increase from USD 1.28 trillion in 2026 to approximately USD 2.34 trillion by 2035, expanding at a CAGR of 7.00% from 2026 to 2035.

According to Precedence Research, regulatory compliance and quality control are emphasized, encouraging similar collaborations in the emerging European network to expand access. Cosmos Health’s partnership with Pharma Cell targets to boost pharmaceutical distribution by demonstrating long-term regional associations that improve access to medicines and supply chain efficiency.

The alliance enhances product access for healthcare providers, reduces shortages, and highlights strategic partnerships over direct market entry. Increasing demand is fostering investments in warehousing, digital systems, transportation, and cold-chain facilities, enabling economies of scale and faster delivery. Improved orders provide stability for distributors by covering inventory, logistics, and procurement.

Impact on the Pharmacy Industry

The global pharmacy market size accounted for USD 1.34 trillion in 2025 and is expected to exceed around USD 1.99 trillion by 2035, growing at a CAGR of 4.03% from 2026 to 2035.

According to Precedence Research, healthcare workers can benefit from reliable distribution, enabling pharmacies to meet demand and reduce delays. The partnership benefits Albania's healthcare by improving pharmaceutical supply, minimizing shortages, and ensuring the stable availability of medicines. This helps manage chronic illnesses, supports preventive care, and enhances health outcomes.

Strengthened partnerships promote safety, product education, and regulatory compliance. Collaborations with international companies and domestic distributors improve infrastructure, upsurge competition, and offer cost-effectiveness. Overall, the partnership creates an opportunity for a robust pharmaceutical system, providing consistent access to quality medicines and strengthening Albania’s healthcare system.

Impact on the Europe Pharmaceutical Industry

According to Precedence Research, Increased activity may increase investments in logistics, warehousing, regulation, and infrastructure, creating opportunities. The announcement highlights growth in Southeast Europe's pharmaceutical sector, supported by rising demand and healthcare expansion. Cosmos Health’s partnership demonstrates how regional collaborations can expand market reach without heavy investments. Albania serves as a strategic gateway to the Balkan region, bolstering pharmaceutical companies to leverage established channels.

This collaboration bolsters Southeast Europe's pharmaceutical market by improving supply chain reliability, attracting investment, and supporting healthcare access, innovation, and competition. Governments and healthcare providers could benefit from upgraded access to medicines and increased supplier competition, thereby improving resilience. Growing orders show increasing confidence in international brands. Rising domestic demand from demographic transition and health system modernization ensures that companies with local operations will thrive.

Expert Opinion

Expert point of view, Cosmos Health’s partnership with Pharma Cell emphasizes regional distribution in the pharma industry. This strategy improves supply chain efficiency by optimizing production, inventory, and logistics, thereby ensuring a reliable supply of medicine. Cosmos focuses on partnerships with a local firm to expand market reach, reducing operational and regulatory hurdles. The projected increase to over 54,000 units indicates rising demand and potential recurring revenue.

The expert said that it strengthens Cosmos’s position in the Balkan market and supports regional expansion, aligning with trends boosting local-global collaborations. Success could lead to more partnerships in the area, creating a larger distribution network. As the European network adapts to healthcare policy changes, it drives investment in operational and commercial capabilities for sustainable practices. Overall, this disciplined approach focuses on improving pharmaceutical access, enabling scalable regional expansion, and boosting Cosmos’s competitiveness across Southeast Europe.